Back

Management of aspirin intolerance in patients undergoing percutaneous coronary intervention: the role of mono anti platelet therapy. A retrospective, multicenter, study.

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Acute coronary syndromes Adjunctive medical therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Matteo Bianco

San Luigi Gonzaga University Hospital, Orbassano (Italy)

72 More presentations in this session

Presentation thumbnail
Professor S. Perlini (Pavia, IT)
Abstract
Presentation thumbnail
Doctor V. Bongard (Toulouse, FR)
Abstract
Presentation thumbnail
Doctor Y. Yang (Taoyuan, TW)
Abstract Slides
Presentation thumbnail
Doctor V. Kashtalap (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Mrs G. Veldre (Tartu, EE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Acute coronary syndromes

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
28 August 2026
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources